Drug discounts: A 743-million-franc scandal revealing OFSP's laxity

AI justification

OFSP's regulatory failure enables systemic financial leakage and undermines healthcare equity. | The OFSP's failure to enforce regulations on pharmaceutical discounts and benefits constitutes a systemic violation of transparency and accountability in public health governance. This undermines equitable access to healthcare (SDG 3) and exacerbates inequalities (SDG 10) by allowing financial leakage that could otherwise reduce healthcare costs for citizens. The lack of oversight also violates the r